These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

151 related items for PubMed ID: 1489634

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [18F-fluorodeoxyglucose positron emission tomography in Parkinson's disease].
    Arahata Y, Kato T, Tadokoro M, Sobue G.
    Nihon Rinsho; 1997 Jan; 55(1):222-6. PubMed ID: 9014454
    [Abstract] [Full Text] [Related]

  • 3. [Cerebral glucose metabolism in dementia (PET-FDG study)].
    Hatazawa J, Itoh M, Matsuzawa T.
    Rinsho Hoshasen; 1989 Oct; 34(11):1343-8. PubMed ID: 2601096
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Patterns of local cerebral glucose utilization determined in Parkinson's disease by the [18F]fluorodeoxyglucose method.
    Kuhl DE, Metter EJ, Riege WH.
    Ann Neurol; 1984 May; 15(5):419-24. PubMed ID: 6610384
    [Abstract] [Full Text] [Related]

  • 6. Cerebral metabolic differences in Parkinson's and Alzheimer's diseases matched for dementia severity.
    Vander Borght T, Minoshima S, Giordani B, Foster NL, Frey KA, Berent S, Albin RL, Koeppe RA, Kuhl DE.
    J Nucl Med; 1997 May; 38(5):797-802. PubMed ID: 9170449
    [Abstract] [Full Text] [Related]

  • 7. Positron emission tomographic (PET) studies in dementia.
    Goto I, Taniwaki T, Hosokawa S, Otsuka M, Ichiya Y, Ichimiya A.
    J Neurol Sci; 1993 Jan; 114(1):1-6. PubMed ID: 8433091
    [Abstract] [Full Text] [Related]

  • 8. Determination of regional rate constants from dynamic FDG-PET studies in Parkinson's disease.
    Piert M, Koeppe RA, Giordani B, Minoshima S, Kuhl DE.
    J Nucl Med; 1996 Jul; 37(7):1115-22. PubMed ID: 8965180
    [Abstract] [Full Text] [Related]

  • 9. Striatal hypometabolism distinguishes striatonigral degeneration from Parkinson's disease.
    Eidelberg D, Takikawa S, Moeller JR, Dhawan V, Redington K, Chaly T, Robeson W, Dahl JR, Margouleff D, Fazzini E.
    Ann Neurol; 1993 May; 33(5):518-27. PubMed ID: 8498828
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Brain glucose metabolism in Parkinson's disease.
    Metter EJ, Kuhl DE, Riege WH.
    Adv Neurol; 1990 May; 53():135-9. PubMed ID: 2239454
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Glucose metabolism and blood flow studies in 2 cases with juvenile Parkinson's disease].
    Shibasaki T.
    Nihon Rinsho; 1997 Jan; 55(1):95-100. PubMed ID: 9014429
    [Abstract] [Full Text] [Related]

  • 15. [F-18 FDG PET in dementia].
    Ichiya Y.
    Rinsho Hoshasen; 1989 Oct; 34(11):1337-41. PubMed ID: 2601095
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Patterns of cerebral glucose utilization in Parkinson's disease and Huntington's disease.
    Kuhl DE, Metter EJ, Riege WH, Markham CH.
    Ann Neurol; 1984 Oct; 15 Suppl():S119-25. PubMed ID: 6234856
    [Abstract] [Full Text] [Related]

  • 18. Functional brain imaging in late-life depression and dementia.
    Kumar A.
    J Clin Psychiatry; 1993 Nov; 54 Suppl():21-5. PubMed ID: 8270594
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. The fluorodeoxyglucose 18F scan in Alzheimer's disease and multi-infarct dementia.
    Benson DF, Kuhl DE, Hawkins RA, Phelps ME, Cummings JL, Tsai SY.
    Arch Neurol; 1983 Nov; 40(12):711-4. PubMed ID: 6605139
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.